Free Cash Flow Chart

View Free Cash Flow for RHHBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 16.37B
December 31, 2025 15.07B
June 30, 2025 14.17B
December 31, 2024 16.25B
June 30, 2024 12.17B
December 31, 2023 12.25B
June 30, 2023 12.64B
December 31, 2022 13.82B
June 30, 2022 18.27B
December 31, 2021 17.41B
June 30, 2021 15.25B
December 31, 2020 12.58B
June 30, 2020 15.58B
December 31, 2019 17.14B
June 30, 2019 14.05B
December 31, 2018 14.64B
June 30, 2018 13.93B
December 31, 2017 13.53B
June 30, 2017 11.66B
December 31, 2016 9.138B
June 30, 2016 9.279B
December 31, 2015 10.43B
June 30, 2015 10.36B
December 31, 2014 12.41B
June 30, 2014 13.78B
Date Value
December 31, 2013 12.72B
June 30, 2013 11.94B
December 31, 2012 11.75B
June 30, 2012 10.89B
December 31, 2011 10.64B
June 30, 2011 11.03B
December 31, 2010 9.438B
June 30, 2010 10.16B
December 31, 2009 12.68B
June 30, 2009 10.51B
December 31, 2008 8.090B
June 30, 2008 10.28B
December 31, 2007 7.666B
June 30, 2007 4.259B
December 31, 2006 5.879B
June 30, 2006 5.651B
December 31, 2005 5.316B
June 30, 2005 3.523B
December 31, 2004 3.898B
June 30, 2004 4.597B
December 31, 2003 3.574B
June 30, 2003 127.80M
December 31, 2002 -846.33M
June 30, 2002 2.348B
December 31, 2001 2.995B

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Novartis AG 14.99B
Eli Lilly & Co. 13.56B
Merck & Co., Inc. 16.06B
AstraZeneca PLC 8.051B
Pfizer Inc. 10.99B

Free Cash Flow Related Metrics